Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the efficacy of MPDL3280A + bevacizumab and MPLD3280A monotherapy compared with sunitinib as measured by progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1) via an independent central radiologic review.
Inclusion criteria
- ADVANCED RENAL CELL CARCINOMA,CARCINOM CU CELULE RENALE AVANSAT, NETRATAT